Australian Clinical Labs Limited (ASX:ACL)
Australia flag Australia · Delayed Price · Currency is AUD
2.620
+0.020 (0.77%)
Sep 8, 2025, 4:10 PM AEST

Australian Clinical Labs Statistics

Total Valuation

ASX:ACL has a market cap or net worth of AUD 509.50 million. The enterprise value is 778.39 million.

Market Cap509.50M
Enterprise Value 778.39M

Important Dates

The last earnings date was Tuesday, August 26, 2025.

Earnings Date Aug 26, 2025
Ex-Dividend Date Sep 1, 2025

Share Statistics

ASX:ACL has 194.47 million shares outstanding. The number of shares has decreased by -4.64% in one year.

Current Share Class 194.47M
Shares Outstanding 194.47M
Shares Change (YoY) -4.64%
Shares Change (QoQ) -11.47%
Owned by Insiders (%) 2.25%
Owned by Institutions (%) 82.84%
Float 187.05M

Valuation Ratios

The trailing PE ratio is 15.37 and the forward PE ratio is 13.61. ASX:ACL's PEG ratio is 0.96.

PE Ratio 15.37
Forward PE 13.61
PS Ratio 0.69
PB Ratio 2.96
P/TBV Ratio 82.91
P/FCF Ratio 2.92
P/OCF Ratio 2.79
PEG Ratio 0.96
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.81, with an EV/FCF ratio of 4.46.

EV / Earnings 24.00
EV / Sales 1.05
EV / EBITDA 3.81
EV / EBIT 11.45
EV / FCF 4.46

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 1.69.

Current Ratio 0.55
Quick Ratio 0.44
Debt / Equity 1.69
Debt / EBITDA 1.42
Debt / FCF 1.67
Interest Coverage 4.66

Financial Efficiency

Return on equity (ROE) is 18.77% and return on invested capital (ROIC) is 8.96%.

Return on Equity (ROE) 18.77%
Return on Assets (ROA) 7.28%
Return on Invested Capital (ROIC) 8.96%
Return on Capital Employed (ROCE) 18.97%
Revenue Per Employee 157,717
Profits Per Employee 6,900
Employee Count4,700
Asset Turnover 1.27
Inventory Turnover 28.99

Taxes

In the past 12 months, ASX:ACL has paid 15.36 million in taxes.

Income Tax 15.36M
Effective Tax Rate 31.88%

Stock Price Statistics

The stock price has decreased by -18.38% in the last 52 weeks. The beta is 1.07, so ASX:ACL's price volatility has been similar to the market average.

Beta (5Y) 1.07
52-Week Price Change -18.38%
50-Day Moving Average 2.75
200-Day Moving Average 3.10
Relative Strength Index (RSI) 44.09
Average Volume (20 Days) 1,532,619

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ASX:ACL had revenue of AUD 741.27 million and earned 32.43 million in profits. Earnings per share was 0.17.

Revenue741.27M
Gross Profit 270.86M
Operating Income 68.00M
Pretax Income 48.18M
Net Income 32.43M
EBITDA 81.36M
EBIT 68.00M
Earnings Per Share (EPS) 0.17
Full Income Statement

Balance Sheet

The company has 22.12 million in cash and 290.38 million in debt, giving a net cash position of -268.26 million or -1.38 per share.

Cash & Cash Equivalents 22.12M
Total Debt 290.38M
Net Cash -268.26M
Net Cash Per Share -1.38
Equity (Book Value) 171.98M
Book Value Per Share 0.88
Working Capital -96.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 182.80 million and capital expenditures -8.41 million, giving a free cash flow of 174.39 million.

Operating Cash Flow 182.80M
Capital Expenditures -8.41M
Free Cash Flow 174.39M
FCF Per Share 0.90
Full Cash Flow Statement

Margins

Gross margin is 36.54%, with operating and profit margins of 9.17% and 4.37%.

Gross Margin 36.54%
Operating Margin 9.17%
Pretax Margin 6.50%
Profit Margin 4.37%
EBITDA Margin 10.98%
EBIT Margin 9.17%
FCF Margin 23.53%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 4.81%.

Dividend Per Share 0.13
Dividend Yield 4.81%
Dividend Growth (YoY) 4.17%
Years of Dividend Growth n/a
Payout Ratio 76.92%
Buyback Yield 4.64%
Shareholder Yield 9.44%
Earnings Yield 6.37%
FCF Yield 34.23%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ASX:ACL has an Altman Z-Score of 2.5 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.5
Piotroski F-Score 7